Bausch & Lomb
Valeant to acquire Bausch & Lomb for $8.7 bn
27 May 2013
Valeant Pharmaceuticals International today said that it will buy out global eye care major Bausch & Lomb Holdings Inc for $8.7 billion in cash from PE firm Warburg Pincus
Canada’s Valeant in talks to buy Bausch & Lomb for $9 bn
25 May 2013
After abandoning its $13 billion cash and stock bid for generic drug giant Actavis, Valeant, one of the most acquisitive pharmaceutical companies, has identified on Bausch and Lomb to strengthen its visual-care products
US eye care firm Bausch & Lomb files for IPO
23 Mar 2013
Advanced Medical outbids Warburg Pincus with $4.23 billion offer for Bausch & Lomb
By Our Corporate Bureau | 07 Jul 2007
Free lens from Bausch & Lomb
By Our Corporate Bureau | 27 Jan 2005
Bausch & Lomb launches Zyoptix 100
By Venkatachari Jagannathan | 27 Jan 2004
Bhai Manjit Singh exits Bausch & Lomb
By Ananth Iyer | 22 May 1999
